What is Phenazoline used for?

Phenazoline is indicated for Allergic conjunctivitis, Allergic rhinitis, Anaphylaxis Adjunct, Dermatographic urticaria, Itching of skin.

Who makes Phenazoline?

Phenazoline is developed by Novartis.

What development phase is Phenazoline in?

Phenazoline is FDA-approved (marketed).

What is the generic name of Phenazoline?

ANTAZOLINE is the generic (nonproprietary) name of Phenazoline.

Last reviewed 2026-04-20 · How we verify

Phenazoline (ANTAZOLINE)

Novartis · FDA-approved approved Small molecule Quality 34/100

At a glance

Generic name	ANTAZOLINE
Sponsor	Novartis
Drug class	antazoline
Target	Histamine H1 receptor
Modality	Small molecule
Therapeutic area	Immunology
Phase	FDA-approved
First approval	1990

Approved indications

Allergic conjunctivitis
Allergic rhinitis
Anaphylaxis Adjunct
Dermatographic urticaria
Itching of skin
Nasal congestion
Nasal discharge
Ocular Itching
Red eye
Sneezing
Urticaria
Vasomotor rhinitis

Common side effects

No common side effects on file.

Key clinical trials

Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation. (PHASE4)
Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation (PHASE4)
Intralesional Bevacizumab Injection on Primary Pterygium (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
FDA label	Mechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Phenazoline CI brief — competitive landscape report
Phenazoline updates RSS · CI watch RSS
Novartis portfolio CI